What is ADAG stock price today?

Visit our real-time dashboard for the current ADAG stock price and live market data.

Is ADAG stock going up or down today?

ADAG stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADAG stock now?

The decision to buy ADAG depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADAG a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADAG based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADAG stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ADAG is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ADAG's P/E ratio?

P/E ratio data for ADAG will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ADAG's market cap?

ADAG (Adagene Inc) has a market capitalization of $0.09 billion, making it a small-cap stock.

What is ADAG's price to book ratio?

Price-to-book ratio for ADAG is available on our dashboard along with other valuation metrics.

Does ADAG pay dividends?

ADAG does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADAG's dividend yield?

ADAG does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADAG stock a good long-term investment?

ADAG's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADAG's revenue growth rate?

Revenue growth data for ADAG is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADAG are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADAG?

Key risks for ADAG include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADAG compare to its competitors?

Compare ADAG to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADAG's performance and positioning.

What is ADAG's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ADAG with bull, base, and bear case scenarios.

What do analysts say about ADAG?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADAG. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADAG's next earnings report?

ADAG reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADAG - Adagene Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Adagene Inc

Adagene Inc (ADAG) common stock

Price Chart

Loading chart...

ADAG Key Statistics

Market Cap

$89.51M

How ADAG Compares to Peers

ADAG is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADAG(This stock)	$89.51M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 2:07 PM EDT

Ready to invest in ADAG?

Commission-free trading available. Affiliate links.

Upcoming Events for ADAG

Dashboard

Enter a ticker to analyze